“…The majority of these were patients with 22q11 microdeletion (Argamaso et al, 1994; Arneja et al, 2008; Boneti et al, 2015; Brandao et al, 2011; Chegar et al, 2007; Crockett et al, 2014; Ettinger et al, 2012; Filip et al, 2013b; Leboulanger et al, 2011; Mehendale et al, 2004; Piotet et al, 2015; Rouillon et al, 2009; Setabutr et al, 2015; Shprintzen, 1988; Sie et al, 1998; Spruijt et al, 2012b). One study looked at management of patients with myotonic dystrophy (Amir et al, 1999), whereas others included patients with rarer syndromes such as Nager (Leboulanger et al, 2011), Sotos (Gray et al, 1999), and Kabuki and Diamond-Blackfan (Setabutr et al, 2015). A small number of papers included results for patients with unspecified syndromes.…”